These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
973 related items for PubMed ID: 6146711
21. Comparative effects of two slow channel calcium entry blockers, FR 34235 and nifedipine, on true coronary collateral blood flow. Gross GJ, Warltier DC, Hardman HF. J Cardiovasc Pharmacol; 1984; 6(1):61-7. PubMed ID: 6199613 [Abstract] [Full Text] [Related]
22. Comparison of calcium channel inhibitors on vagal heart rate responses elicited by arterial baroreceptor reflexes in anesthetized dogs. Taylor DG, Kowalski TE. J Pharmacol Exp Ther; 1984 Feb; 228(2):491-9. PubMed ID: 6694122 [Abstract] [Full Text] [Related]
23. Studies on the comparative coronary vasodilator, vasodepressor and antiarrhythmic actions of gallopamil (D-600) and nisoldipine (Bay K 5552). Basu DK, Brahmankar DM. Mater Med Pol; 1985 Feb; 17(2):103-6. PubMed ID: 4079466 [No Abstract] [Full Text] [Related]
24. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade. Duncker DJ, Hartog JM, Hugenholtz PG, Saxena PR, Verdouw PD. Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886 [Abstract] [Full Text] [Related]
25. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs. Kanda A, Haruno A, Miyake H, Nagasaka M. J Cardiovasc Pharmacol; 1992 May; 20(5):723-30. PubMed ID: 1280733 [Abstract] [Full Text] [Related]
26. Antianginal effects of the new calcium antagonist benidipine hydrochloride in anesthetized rats and spontaneously hypertensive rats. Electrocardiographic study. Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N. Arzneimittelforschung; 1988 Nov; 38(11A):1702-7. PubMed ID: 3219144 [Abstract] [Full Text] [Related]
27. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease. Pouleur H, Etienne J, Van Mechelen H, Van Eyll C, Charlier AA, Brasseur LA, Rousseau MF. Postgrad Med J; 1984 Nov; 60 Suppl 4():23-8. PubMed ID: 6527976 [Abstract] [Full Text] [Related]
28. Cardiovascular effects of YM-16151-4: a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent in rats and dogs. Uchida W, Shibasaki K, Matsuda Y, Asano M, Takenaka T. J Cardiovasc Pharmacol; 1993 Aug; 22(2):247-52. PubMed ID: 7692165 [Abstract] [Full Text] [Related]
29. [Calcium antagonists: effect on peripheral and coronary hemodynamics]. Simon R. Z Kardiol; 1984 Aug; 73 Suppl 2():79-88. PubMed ID: 6528705 [Abstract] [Full Text] [Related]
30. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium. Imai H, Matsui K, Ochi S, Nakazawa M, Nakagawa Y, Imai S. Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062 [Abstract] [Full Text] [Related]
31. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment. Pedrinelli R, Tarazi RC. J Pharmacol Exp Ther; 1985 Jun; 233(3):636-42. PubMed ID: 2989491 [Abstract] [Full Text] [Related]
32. Negative chronotropic actions of sufentanil and vecuronium in chronically instrumented dogs pretreated with propranolol and/or diltiazem. Schmeling WT, Kampine JP, Warltier DC. Anesth Analg; 1989 Jul; 69(1):4-14. PubMed ID: 2568103 [Abstract] [Full Text] [Related]
33. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine. Zyvoloski MG, Brooks HL, Gross GJ, Warltier DC. J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568 [Abstract] [Full Text] [Related]
34. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog. Satoh K, Kawada M, Wada Y, Taira N. Arzneimittelforschung; 1984 Aug; 34(5):563-8. PubMed ID: 6540573 [Abstract] [Full Text] [Related]
36. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ, Haitsma DB, van der Geest IE, Stubenitsky R, van Meegen JR, Man in't Veld AJ, Verdouw PD. Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [Abstract] [Full Text] [Related]
37. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs. Mori T, Nakayama N, Ohura M, Ikezono K, Kinoshita S, Kamata M, Hosokawa T, Yamashita S, Yabuuchi Y. Arch Int Pharmacodyn Ther; 1993 Mar; 321():41-56. PubMed ID: 8323415 [Abstract] [Full Text] [Related]
38. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs. Takata Y, Kato H. Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208 [Abstract] [Full Text] [Related]
39. [Pharmacological control of heart rate]. Sirtori CR, Franceschini G. Ann Ital Med Int; 1994 Oct; 9 Suppl():29S-35S. PubMed ID: 7857754 [Abstract] [Full Text] [Related]
40. Haemodynamic effects of lercanidipine in anaesthetized open-chest dogs. Sironi G, Montagna E, Greto L, Leonardi A, Testa R. Arzneimittelforschung; 1996 Mar; 46(3):256-61. PubMed ID: 8901145 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]